Skip to main content
Inventiva logo

Inventiva — Investor Relations & Filings

Ticker · IVA ISIN · FR0013233012 LEI · 969500I9Y690B3FZW590 PA Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2022-05-16 Capital/Financing Update
Country FR France
Listing PA IVA

About Inventiva

https://inventivapharma.com/

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas include fibrotic diseases, lysosomal storage disorders, and oncology. Its lead product candidate, lanifibranor, is a pan-PPAR (peroxisome proliferator-activated receptor) agonist being evaluated in a pivotal Phase III clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). Lanifibranor is designed to address the key features of NASH, including steatosis, inflammation, ballooning, and fibrosis. The candidate has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) based on positive Phase IIb results.

Recent filings

Filing Released Lang Actions
Inventiva secures a €50 million credit facility from the European Investment Bank
Capital/Financing Update Classification · 99% confidence The document is explicitly titled "COMMUNIQUE DE PRESSE" (Press Release) and announces a specific corporate event: securing a €50 million credit facility from the European Investment Bank (EIB). This type of announcement, detailing financing activities, capital structure changes, or significant corporate agreements, aligns best with the 'Capital/Financing Update' category. It is not a full annual report (10-K), an earnings release (ER), or a transcript (CT). Since it is a direct announcement of a financing event, 'CAP' is the most appropriate classification, rather than the general 'RNS' fallback.
2022-05-16 English
Inventiva obtient un crédit d’un montant de 50 millions d’euros de la part de la Banque Européenne d’Investissement
Capital/Financing Update Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" (COMMUNIQUE DE PRESSE) and announces a specific corporate event: securing a €50 million credit facility from the European Investment Bank (EIB). This type of announcement, detailing financing activities, capital structure changes, or major funding agreements, directly aligns with the definition of a Capital/Financing Update. It is not a full Annual Report (10-K), an Earnings Release (ER) focusing on operational results, or a mere announcement of a report (RPA). The content focuses entirely on the terms, tranches, and intended use of the new debt financing.
2022-05-16 French
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Statement of total voting rights and shares forming the company's share capital as of April 11, 2022". It explicitly details the number of outstanding shares and the total voting rights (gross and net) as required by French Commercial Code Article R. 22-10-23. This type of mandatory periodic disclosure, which reports on the current capital structure and voting power, is best classified as a notification related to share capital changes or major shareholdings, although it is a specific, recurring regulatory update. Given the options, it most closely relates to changes in the share structure or ownership reporting. Since it is a formal statement of the total number of shares and voting rights, it is a specific type of regulatory filing. It is not an AGM presentation, an earnings release, a full annual report (10-K), or a management discussion (MDA). It is a direct notification about the share count. The closest fit among the provided codes that deals with capital structure or significant ownership reporting is 'Major Shareholding Notification' (MRQ) or 'Share Issue/Capital Change' (SHA). However, this specific report is a mandatory disclosure of the *total* share capital and voting rights, which is often a distinct regulatory requirement separate from a single transaction (SHA/POS) or crossing a threshold (MRQ). Since it is a formal, periodic regulatory statement about the capital base, and given the options, 'Major Shareholding Notification' (MRQ) is often used broadly for disclosures impacting shareholder voting power, or 'Regulatory Filings' (RNS) as a fallback. Because the content is a direct, formal statement of the total voting rights, which is a key input for shareholder decisions and regulatory oversight, it aligns well with the concept of reporting significant capital structure facts. In many jurisdictions, this specific report is mandated alongside proxy materials or as a standalone filing. Given the precise nature of the data (total shares and voting rights), and lacking a specific 'Total Voting Rights Statement' code, I will classify it as a 'Major Shareholding Notification' (MRQ) as it directly impacts the calculation of voting power, or RNS. Given the context of French regulation (AMF), these statements are mandatory disclosures. I will lean towards MRQ as it relates to the structure underpinning voting rights, or RNS as a general regulatory filing. Since it is a formal, periodic statement of the capital base, and not an announcement *about* a report, I will select MRQ as the most specific fit related to shareholder structure/voting rights, though RNS is also plausible.
2022-04-28 English
Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information relative au nombre total de droits de vote et d'actions composant le capital social au 11 avril 2022" and explicitly details the total number of voting rights and shares as of a specific date (April 11, 2022), referencing the French Commercial Code (Article R. 22-10-23) and AMF regulations. This type of mandatory disclosure, which reports the total voting power (droits bruts/nets) on a specific date, is typically filed when a threshold is crossed or periodically as required by market regulators. While it is presented as a 'COMMUNIQUE DE PRESSE' (Press Release), its core content is a formal regulatory disclosure regarding capital structure and voting rights. This specific content aligns most closely with a notification of changes in significant share ownership or capital structure reporting, but the most precise fit among the provided codes for a formal, periodic disclosure of voting rights/share capital count is often captured under general regulatory announcements or specific capital change notifications. Given the focus on the total number of shares and voting rights, it relates to the capital structure. However, since it is a formal announcement of a specific regulatory metric (voting rights count) and not a general capital change (SHA) or a major shareholding notification (MRQ) by an external party, it fits best as a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if interpreted broadly. Since it is a mandatory disclosure of the total share capital/voting rights count, which is a fundamental regulatory reporting requirement, RNS (Regulatory Filings - general fallback for mandatory disclosures) is appropriate, although it shares characteristics with SHA. Given the context of mandatory disclosure of voting rights count, RNS is the safest general classification for this type of regulatory update that isn't a full financial report or a specific insider trade/shareholder change.
2022-04-28 French
Assemblée Générale Mixte du 19 mai 2022 - Modalités de mise à disposition des documents préparatoires
AGM Information Classification · 98% confidence The document is titled "Assemblée Générale Mixte du 19 mai 2022 Modalités de mise à disposition des documents préparatoires" (Combined General Meeting of May 19, 2022 Modalities for making preparatory documents available). It explicitly discusses the arrangements, agenda, and availability of documents for the upcoming Annual General Meeting (AGM) scheduled for May 19, 2022. This content directly relates to the materials and announcements surrounding the AGM. Therefore, the appropriate classification is AGM Information (AGM-R). Although it mentions the availability of documents, the primary focus is the meeting itself and its preparatory details, making AGM-R more specific than RPA or RNS.
2022-04-28 French
Combined General Meeting of May 19, 2022 - Availability of the preparatory documents
Report Publication Announcement Classification · 99% confidence The document is a press release dated April 28, 2022, announcing the 'Availability of the preparatory documents for the Combined General Meeting of May 19, 2022.' It explicitly states that the notice of meeting, agenda, and draft resolutions are available and details how shareholders can access these documents for the upcoming General Meeting. This content directly relates to the materials prepared for a shareholder meeting, which aligns perfectly with the definition of AGM Information (AGM-R) or, more specifically, the announcement of those materials, which often falls under Proxy Solicitation & Information Statement (PSI) or AGM-R. Since the core subject is the availability of preparatory documents for the AGM, AGM-R is the most precise fit, as it covers 'Presentations and materials shared during the Annual General Meeting (AGM).' Although it announces the availability (suggesting RPA), the content is the substance of the AGM materials themselves, making AGM-R a stronger classification than a generic RPA.
2022-04-28 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.